Thanks for choosing mmm-online.com Sign up for your FREE account now and join the thousands of other healthcare marketing professionals who rely on us for all the latest industry news and innovative ideas for direct and digital strategy. Simply fill out the fields below.

Keep me logged in Forgot your password?

Please wait...

Please wait...

Web Exclusives

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 
Web Exclusives

Consumers Must Make Own Choices as Health Guidelines Change

Nancy Hicks April 19, 2013

Welcome to the ambivalent world of healthcare, where confusion reigns as shifts in science and guidelines seemingly raise more questions than they answer.
 
Web Exclusives

Novartis makes, the world takes

Peter Pitts April 12, 2013

India, a nation known for its innovation in many areas, has decided that incremental innovation in pharmaceuticals isn't important—at least when it comes to patent protection
 
Web Exclusives

Ready for Healthcare Anywhere?

Joe Shields April 03, 2013

Healthcare is moving from its traditional two places for delivery—the hospital and the doctor's office—to the patient, aided in part by mobile devices and always-on connectivity.
 
Web Exclusives

Why SGLT-2s may put some spring into pharma spending

Jerry Maynor March 28, 2013

Should the FDA give the thumbs-up to J&J diabetes pill Invokana tomorrow, expect a blockbuster US marketing push, says CSD's Jerry Maynor.
 
Web Exclusives

Coming face-to-face with advanced cancer

March 22, 2013

A relative's illness challenges a pharma consultant's view of industry progress.
 
Web Exclusives

AMARC Angst: Has FDA put pharma Facebook "Likes" in the crosshairs?

Peter Pitts March 08, 2013

What the agency writes in a recent warning letter to a dietary supplement firm is instructive with regard to "Liking" off-label posts.
 
Web Exclusives

DDR at the movies: "Side Effects"

Deborah Dick-Rath February 20, 2013

When Hollywood shines its spotlight on your industry, you never know how you're going to be portrayed. In "Side Effects," the view is less than flattering.
 
Web Exclusives

Op/ed: A way for biopharma to disclose more trial data

Ken Getz December 26, 2012

At a time when some regulatory bodies and biopharma companies are increasing their transparency initiatives involving access to clinical-trial data, disclosing trial results to volunteers could also go a long way toward strengthening public confidence.
 
Web Exclusives

Op/Ed: Meningitis crisis and the threat to pharma

October 10, 2012

The deadly meningitis outbreak highlights the threat not only to public health, but also to the pharma industry, posed by the largely unregulated practice of pharmacy compounding.
 
Web Exclusives

Five industry experts advise specialty pharma company on digital strategy

April 20, 2012

Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
 
Web Exclusives

WEB EXCLUSIVE: Pharmas must step up and lead on off-label, online communications

John Kamp January 03, 2012

FDA's recent draft guidance on off-label communication is, despite its shortcomings, a step forward, writes John Kamp, arguing that pharmas should take this welcome bit of clarity and act boldly on it
 
Web Exclusives

WEB EXCLUSIVE: FDA says "Pharma, guide thyself"

Peter Pitts January 03, 2012

FDA's first draft guidance to come out of its 2009 online communication hearing offers sound counsel but not much in the way of specifics, writes Peter Pitts. The takeaway: where the letter of the law is hazy, exercise your judgement and follow, as best you can, the spirit of the law.
 
Web Exclusives

WEB EXCLUSIVE - Pragmatism vs. Possibility: the false pharma fight over the iPad

Bill Drummy July 26, 2011

The pace of adoption of the iPad continues to startle, and already half of the top 20 pharma companies have bought into the tablet platform. But now comes the tricky part: how will pharma actually use their fancy new machines? Bill Drummy reports.
 
  

Web Exclusive

Angelina Jolie's fearless but flawed message

Paul Oestreicher, Ph.D. May 17, 2013

Angelina Jolie's story raises important questions about education, outreach and access—but her nod to holistic treatments is less helpful
 

Podcasts

How to engage even the busiest physicians

March 04, 2013

Sponsored by TRUE Health + Wellness. The increasingly demanding schedules of healthcare professionals continue to narrow the window of opportunity for pharma sales teams, and, as a result, marketers are focusing more on non-personal promotion. However, there's a lot more to it than simply bombarding physicians with brand messages, as Anne Stroup, Managing Director at TRUE Health + Wellness, explains to MM&M's James Chase in this special podcast presentation.
 

2013 Hall of Fame Inductees

An entertaining look at the extraordinary lives and careers of the Medical Advertising Hall of Fame's 2013 inductees: Peter Frishauf, Dorothy Philips and David Labson. Clips produced by JUICE Pharma. 

Slideshows

MAHF 2013: Honors Class

A gallery of images from the 2013 Medical Advertising Hall of Fame induction dinner
 
Popular Topics
Acquisition Adherence Advertising App Centers For Disease Control Clinical Trial Consumer COPD Diabetes DTC Elan FDA Generic Generic Drugs iPad Lymphoma Marketing & Communications Merck Mobile Obesity Oncology Patent Cliff Patient Advocacy Patients Regulatory